SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves Q3 results beat expectations, raised full-year guidance and highlighted a large AI-compute backlog, prompting traders to debate whether demand and customer prepayments can support continued expansion. Bullish reactions point to stronger growth and financing plans, while skeptics focus on heavy debt, interest costs, rising capital spending and dilution risk; the stocks muted reaction has intensified that divide.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on the FDAs pending decision on Capricors Duchenne treatment deramiocel, with traders parsing the Q3 call and CEO Lindas confidence for clues about approval and possible cardiac-label coverage. Many are bullish and cite launch preparations, while others stress that approval remains uncertain and the call offered no definitive FDA update.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlists Q3 results and conference-call outlook are driving attention, with traders highlighting stronger profitability and margins, Samsung licensing revenue, and expected Micron payments in the next quarter. Many are bullish, while others question the drop in product sales and the lack of concrete updates on an SK hynix deal or Nasdaq uplisting.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigettis shares are under pressure after its Q3 results missed expectations and its revenue outlook disappointed, intensifying concerns about valuation, cash burn and the long path to commercialization. Traders are divided between skeptics focused on weak near-term business performance and bulls who see progress in its quantum technology as a longer-term opportunity.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidias selloff is dominated by scrutiny of CEO Jensen Huang over his reported relationship with an alleged Chinese intelligence operative and questions about possible restricted chip shipments to China; the allegations remain unproven. Traders are split between fearing an investigation, regulatory fallout or Huangs departure and viewing the drop as an overreaction and a buying opportunity, with some also pointing to broader weakness in AI stocks.

Amprius Technologies, Inc. engages in the development, manufacture, and market of lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the following geographical segments: North America, EMEA, and Asia Pacific. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius Q3 results are driving attention: revenue growth and a higher full-year revenue outlook were offset by an EPS miss and weaker adjusted EBITDA guidance, prompting a selloff. Traders are split between viewing the reaction as an overreaction to the miss and worrying about profitability and cash burn.

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Costcos announcement of a large special cash dividend and renewed share-buyback authorization is driving attention, with traders reacting positively and discussing eligibility for the payout. Some also question whether the rally can hold given the stocks rich valuation and warn of a possible sell-the-news pullback.

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Kura Oncology Inc

Kuras quarterly results and KOMZIFTI launch growth are driving discussion, with traders highlighting rising prescriptions and patient starts while debating whether J&Js competing menin-inhibitor data could threaten its position. The prospectus and share issuance also drew some concern about dilution.

LightPath Technologies, Inc. engages in the design, development, manufacture, and distribution of optical and infrared components. Its products include molded glass and assemblies, infrared molded lenses, diamond turned, conventional ground and polished ground lenses and assemblies, and collimator assemblies, which are used in applications involving light detection and ranging technology. The firm supports a range of customers in the field of industrial, laser, defense, medical, telecommunications, and instrumentation. The company was founded in1985 and is headquartered in Orlando, FL.

Lightpath Technologies, Inc. - Ordinary Shares - Class A

LightPaths fiscal Q1 results and record funded backlog are driving discussion, alongside plans to scale production of optics for defense and drone systems. Bulls see strong demand and growth potential, while skeptics question whether execution and deliveries will catch up with managements outlook.

ETF Opportunities Trust - T-REX 2X Inverse CRWV Daily Target ETF

T-REX 2X Inverse CRWV Daily Target ETF

Traders are using CORD, a 2x inverse CoreWeave ETF, to bet on or hedge against declines in CRWV, with bearish comments citing debt, dilution and spending concerns. Others expect CRWV to remain strong or rebound, and many frame CORD as a volatile short-term trade rather than a long-term holding.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tariffs Turmoil: Weather the Storm With These Dividend Stocks

Others

Nvidia Posts Record Q4 Earnings, Here’s How it Stacked Up With Analyst Projections

Why Trump’s Memecoin and Bitcoin Hit Record Highs on Inauguration Day

Cryptocurrency

As Donald Trump was sworn in for his second term in office, completing an unprecedented political comeback, crypto markets were surging, led by Bitcoin and the new TRUMP memecoin.


Here’s Why the Crypto Market is Surging Today

The crypto market soared again today, fueled by better-than-expected inflation data and bullish sentiment surrounding the incoming Trump administration’s favourable policies.


Core Inflation Eases in December, Here’s Where the Fed Rate-Cut Odds Stand

Favorable inflation data, renewed rate cut hopes, and strong Q4 earnings from the big banks saw Wall Street surge on Wednesday.


Insurance Nightmare: Why Thousands Had Policies Canceled Before LA Wildfires

Despite dropping thousands of policies in the months before the wildfires broke out, insurance companies are facing steep losses, with estimated damages from the fires already exceeding $250 billion.

Tiny Healthcare Stock With $35 Million Market Cap Becomes Major Player Overnight in Rapidly Growing $1 Billion Market

Therma Bright secures Medicare codes for its Venowave VW5, boosting its market presence in the $1.5B DVT market and driving an 800% stock surge since May 2024.

Therma Bright Gains Medicare Code for Venowave, Stock Soars

Equity

Therma Bright (TSXV: THRM) secures permanent Medicare and Medicaid reimbursement codes for its Venowave VW5 device, making it the only DVT treatment with such codes. This innovation has driven significant stock gains, with shares rising over 800% since May 2024.

Ryan Troupe

Latest Articles from Ryan Troupe